Recent studies have identified a family of DNA-binding proteins that share a common DNA-binding and dimerization domain with the potential to form a helix-loop-helix (HLH) structure. Various HLH proteins can form heterodimers that bind to a common DNA sequence, termed the E2-box. We demonstrate here that E2-box-binding B-cell-and myocyte-specific nuclear factors contain subunits which are identical or closely related to ubiquitously expressed (E12/E47) HLH proteins. These biochemical data suggest a pleiotropic function for E12/E47-like molecules in mammalian differentiation, similar to the genetically defined function of daughterless in Drosophia development.
One class of DNA-binding proteins contains a region of homology that has the potential to form a helix-loop-helix (HLH) structure preceded by a highly basic region (22) ; this region has been shown to contain a DNA-binding and dimerization domain (12, 22, 29) . Certain HLH homo-and heterodimers bind to a common DNA sequence, termed the E2-box. The E2-box is present in the immunoglobulin heavyand light-chain gene enhancer, the insulin gene enhancer, and the muscle creatine kinase gene enhancer (4, 7, 19, 20) . In each of these enhancers it plays a crucial role in the regulation of tissue-specific gene expression. Representative members of the HLH family that bind the E2-box are E12 (pan-1), E47 (E2-5; pan-2), and E2-2 (16, 22, 24) immunoglobulin enhancer-binding proteins; MyoD (12) , myogenin (3, 31) , and myf-5 (2), three proteins that induce myogenesis; and daughterless (da) (6, (8) (9) (10) (11) and achaete-scute (28) , Drosophila genes that are involved in cell determination and differentiation. In vitro evidence implies that classes of HLH proteins use combinatorial interactions to control tissuespecific gene expression in various developmental pathways (21) . Class A includes ubiquitously expressed proteins da, E12, E2-2, and E47. E12 and E47 are differentially spliced products of the same gene (26b) and share most of their amino acid sequence. All four proteins have very closely related HLH motifs. Class B includes tissue-specific proteins, MyoD, myogenin, myf-5, and members of the achaetescute gene family. Class B proteins bind in vitro with high affinity to the E2-box as heterodimers with class A proteins. In addition, there is a class of HLH proteins which lack a basic region and thus are negative regulators of DNA binding (Id, extramacrochaete) (1, 14, 15 (25) .
Extract preparation and gel shift assays. Nuclear extracts were prepared exactly as described by Dignam et al. (13) . Oligonucleotides containing the wild-type monomeric 1xE2 and muscle creatine kinase E2-box sequence were 32p labeled (50,000 cpm/ng), and 0.5 ng of DNA probe was incubated with 3 to 10 ,ug of nuclear extract. The KE2 probe was derived from a restriction fragment as described previously (22) . The analyzed by using the E2-box present in the muscle creatine kinase enhancer as a probe; 2, WEHI 231 extract analyzed by using the E2-box present in the KE2 site of the kappa light-chain enhancer as a probe; 3, WEHI 231 extract analyzed by using the E2-box present in the pLE5 site of the immunoglobulin heavy-chain enhancer as a probe. MEF, Muscle-specific complexes; NS, nonspecific DNA-binding proteins.
RESULTS
B-cell-specific E2-box DNA-binding proteins. B-cell-specific proteins binding to the E-box sites in the immunoglobulin heavy-chain enhancer were first detected by in vivo methylation protection experiments (7) . Previous studies with low-ionic-strength gel systems failed to detect such B-cell-specific E2-box-binding proteins in vitro (17, 19) . Recently, tissue-specific E2-box-binding proteins were found in muscle-derived nuclear extracts (3, 4, 18) . To look for other tissue-specific E2-box-binding proteins, we screened a wide variety of nuclear extracts by using an electrophoretic mobility shift assay (EMSA) at high ionic strength. As demonstrated before (3, 4, 18) , muscle-specific proteins, designated as MEF-1, are present in myocyte nuclear extracts and bind the E2-box sequence present in the muscle creatine kinase enhancer (Fig. 1A, To determine whether the B-cell-and myocyte-specific complexes interact with the E2-box in a specific manner, we performed a competition analysis. DNA containing the wildtype E2-box sequence, derived from the muscle creatine kinase enhancer (GCAGGTGT), did compete for BCF1 and BCF2 binding (Fig. 1B, lane 2 3) with high affinity, but binding to the KE2 site was weaker and qualitatively different (lane 2). The faster-migrating complex binding to the KE2 site was nonspecific. Thus, BCF complexes bind to sequences that are important for immunoglobulin heavy-and light-chain gene expression (17, 19) .
B-cell-specific E2-box DNA-binding complexes contain E12/ E47-like subunits. E47 protein can transactivate a reporter gene containing multiple ,uE5 and KE2 sequences positioned 5' of its promoter (16, 29a) , suggesting that E47 is part of a transcriptional complex binding to the ,uE5 and KE2 motifs. To test whether the BCF complexes contain E12/E47 molecules, B-cell nuclear extracts derived from WEHI 231 were incubated with anti-E12/E47 antiserum and assayed by EMSA. The antiserum does not recognize determinants present in the conserved HLH motif or determinants present in other related HLH proteins, for example MyoD, Id, and myogenin among the tested molecules (1, 21, 31) . Thus, it is specific for E12 and E47 polypeptides, although we cannot exclude the possibility that other closely related polypeptides share determinants with E12/E47. The anti-E12/E47 antibody, however, does not distinguish between E12 and E47 polypeptides (21) . Both the BCF1 and BCF2 complexes supershifted (migrated more slowly) in the presence of the anti-E12/E47 antibody (Fig. 2, lane 5) , whereas preimmune serum did not affect complex mobility (lane 6). Thus, BCF1 and BCF2 contain E47-and/or E12-like molecules. BCF1 and BCF2 are present, nuclear extracts derived from different B-cell lines were examined by EMSA with the E2-box, derived from the muscle creatine kinase enhancer, as a probe. Both BCF1 and BCF2 were detected in pre-B-cell and mature B-cell lines (Fig. 3, lanes 3 and 4) , but not in pro-B-cell lines (a kind gift of R. Palacios) (lanes 1 and 2) (27) . We have examined four additional pre-B-cell and mature B-cell lines; they all contain the B-cell-specific BCF1 and BCF2 complexes (data not shown). The faster-migrating band present in pro-B cells is nonspecific (20a) . Mature B and pre-B-cell lines, but not the pro-B-cell lines examined here, express immunoglobulin heavy chain. The presence of BCF1 and BCF2 therefore correlates with immunoglobulin heavy-chain gene expression.
Myocyte-specific E2-box DNA-binding proteins contain E12/ E47-like subunits. Previously we have shown that E12 and E47 proteins can interact with MyoD in vitro to form heterodimers that bind to the E2-box motif (21) . Myocyte nuclear extracts contain muscle-specific complexes that are identical or antigenically related to MyoD and myogenin (18) . To determine whether E12/E47-like proteins form heterodimers with MyoD and myogenin in vivo, myocyte nuclear extracts were incubated with an anti-E12/E47 antibody and analyzed by EMSA. The muscle-specific complexes reacted with the antibody (Fig. 2, lane 2) the muscle-specific complexes, the relative ability of the antiserum to supershift the complexes was 100-fold lower for the muscle-specific complexes than for the BCF proteins (20a) . A trivial explanation for this difference in affinity could be that BCF1 and BCF2 are homo-oligomers of E12/E47. To address this issue, we have examined the relative affinity of the anti-E12/E47 antibody for in vitro-synthesized E47 homo-oligomers and E47-MyoD heterodimers. E47 homooligomers have a 100-fold-higher affinity for the antibody than do E47-MyoD heterodimers (20a) . In addition, in vitrotranslated full-length E47 generated two complexes that comigrated with the BCF1 and BCF2 complexes present in nuclear extracts frotn a pre-B-cell line, PD31 (Fig. 4, lanes 1  and 2) . Why the in vitro E47-synthesized molecules generate two complexes with different mobilities in an EMSA is not clear. They either could represent variable complexes of E47, for example a dimer (BCF2) and a tetramer (BCF1), or could result from posttranslational modification. To determine whether the product of E47 cDNA migrates with similar mobility' when expressed in vivo, a full-length E47 cDNA placed under the control of the cytomegalovirus promoter was introduced transiently into HeLa cells. Nuclear extracts derived from HeLa cells transfected with E47 cDNA were then examined by EMSA. Two complexes were apparent in the extracts prepared from the transfected cells but not from the control cells. These complexes comigrated exactly with BCF1 and BCF2 (Fig. 4, lanes 3 and 4) and were supershifted by the anti-E12/E47 antibody (data not shown). These data suggest that the BCF proteins might consist of oligomers of E47 or E12 or a closely related protein. In addition, in vitro-translated E47 polypeptide and BCF proteins have very similar affinities to anti-E12fE47 antibody (20a) , which further supports the idea that the BCF proteins are indeed oligomers of E12 or E47. It is unlikely that BCF1 and BCF2 represent homo-oligomers of E12, because E12 homo-oligomers have a relatively weak affinity for the E2 sequence under the conditions described here (22) . Thus, BCF1 and BCF2 most probably represent homo-oligomers of E47 or hetero-oligomers containing E12 and E47. We note, however, that further analysis of these complexes is required to exclude the possibility that a B-cell-specific polypeptide associates with E47 or E12 in BCF1 and BCF2.
DISCUSSION
We have presented data showing that both myocyte and B-cell E2-box DNA-binding proteins contain E12/E47-like subunits. In B-cell nuclear extracts, complexes containing E47 subunits-very probably consisting of a homo-oligomer of E47-are present that cannot be detected in non-B cells. E12 and E47 mRNA has been detected in all cell types examined (22) . We have immunoprecipitated E12/E47 polypeptides from Jurkat and HeLa cells (20a) . Why are apparent E47 homo-oligomers detected in nuclear extracts derived from B cells but not in those of other cell types? One possibility is that in many cells E47 polypeptides are complexed with other HLH polypeptides, such as Id, that would inhibit their DNA binding (1) . Id was shown to form heterodimers with E47 in vitro, inactivating its ability to bind to DNA. Id levels are low in differentiated cell types, whereas they are high in undifferentiated cells (1) . High levels of Id might inhibit the DNA-binding activity or HLH proteins such as E47. In pro-B and other cell types, levels of inhibitory molecules identical or related to Id might be high, preventing E47 from forming homo-oligomers (24a). During B-cell differentiation, similarly to myogenesis, levels of such inhibitory molecules might drop, allowing E47 polypeptides to form oligomers that can now bind to regulatory sequences present in the immunoglobulin heavy-and light-chain gene enhancers, inducing their transcription and subsequently B-cell differentiation. In other cells, the presence of class B HLH proteins such as MyoD would lead to preferential heterodimer formation (26b) and suppress the homo-oligomers.
These data suggest that the role of E12/E47-like proteins in mammalian development might be similar to that of da in Drosophila. da is a gene whose various mutants show pleiotropic effects. da controls both sex determination and neurogenesis (9) . A role for da in other developmental pathways is likely, but evidence is lacking because of the lethality of da mutations. The physical similarity between da and E12/E47 proteins is striking. The E12/E47 sequences are as related to da in the region surrounding the HLH region as they are to each other (22) . In addition, each of the proteins is ubiquitously expressed. In this paper we present data suggesting a role for E12/E47-like proteins in myogenesis and B-cell development. A role for E12/E47 proteins in pancreatic p-cell differentiation is likely as well. The E2-box sequence is present in the insulin enhancer, a site that has been shown to be crucial for its tissue-specific expression (20, 24) . Indeed, Stein and collaborators recently found that a p-cell-specific complex that binds the E2-box is supershifted with an anti-E12/E47 antibody (26a, 30). They also found that the activity of the E2 regulatory sequence present in the insulin enhancer is responsive to Id. Thus, E12/E47 VOL. 1 l, 1991 and related molecules may well function in controlling development by associating either with tissue-specific components, such as MyoD in MEF-1, or as homo-oligomers in the BCF proteins, inducing the differentiated-muscle-, B-cell-, and P-cell-specific phenotypes.
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